115
Participants
Start Date
July 2, 2019
Primary Completion Date
September 30, 2025
Study Completion Date
December 31, 2025
Beinaglutide
Beinaglutide (continuous subcutaneous infusion)
Insulin aspart
Insulin aspart (CSII)
RECRUITING
First Hospital of Peking University, Beijing
RECRUITING
Heilongjiang provincial hospital, Harbin
RECRUITING
Henan People's Hospital, Zhengzhou
RECRUITING
Pinggu District Hospital, Beijing
RECRUITING
Southern Medical University Nanfang Hospital, Guangzhou
RECRUITING
Southeast University Zhongda Hospital, Nanjing
RECRUITING
Xi'an Jiaotong University Second Hospital, Xi'an
RECRUITING
Southwest Medical University Affiliated Hospital, Luzhou
RECRUITING
Capital Medical University Beijing Anzhen Hospital, Beijing
RECRUITING
Emergency General Hospital, Beijing
RECRUITING
Peking University Shougang Hospital, Beijing
RECRUITING
Harbin Medical University Second Hospital, Harbin
RECRUITING
Xuzhou Medical University Affiliated Hospital, Xuzhou
RECRUITING
China-Japan Union Hospital of Jilin University, Changchun
RECRUITING
Jilin University Second Hospital, Changchun
RECRUITING
Peking University Binhai Hospital, Tianjin
Beijing Hospital
OTHER_GOV